Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of McKesson Corporation (NYSE:MCK). In a filing disclosed on December 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in McKesson stock on November 18th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of First Watch Restaurant Group (NASDAQ:FWRG) on 11/26/2025.
- Purchased $1,001 – $15,000 in shares of TKO Group (NYSE:TKO) on 11/26/2025.
- Sold $1,001 – $15,000 in shares of RBC Bearings (NYSE:RBC) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 11/24/2025.
- Purchased $1,001 – $15,000 in shares of Logan Energy (CVE:LGN) on 11/24/2025.
- Sold $1,001 – $15,000 in shares of Primoris Services (NASDAQ:PRIM) on 11/24/2025.
- Purchased $15,001 – $50,000 in shares of LandBridge (NYSE:LB) on 11/21/2025.
- Purchased $50,001 – $100,000 in shares of LandBridge (NYSE:LB) on 11/20/2025.
McKesson Stock Up 1.2%
Shares of NYSE:MCK traded up $9.36 on Friday, reaching $819.92. The company had a trading volume of 1,419,784 shares, compared to its average volume of 846,214. The stock has a market capitalization of $101.20 billion, a P/E ratio of 25.52, a P/E/G ratio of 1.33 and a beta of 0.38. The stock has a 50-day moving average price of $825.11 and a 200 day moving average price of $750.80. McKesson Corporation has a twelve month low of $565.75 and a twelve month high of $895.58.
McKesson Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, December 1st. McKesson’s dividend payout ratio (DPR) is 10.21%.
Institutional Investors Weigh In On McKesson
Several large investors have recently modified their holdings of the stock. GGM Financials LLC bought a new position in shares of McKesson in the third quarter valued at approximately $25,000. Solstein Capital LLC increased its holdings in McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after purchasing an additional 24 shares in the last quarter. State of Wyoming bought a new position in McKesson in the 2nd quarter valued at $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the 3rd quarter valued at $31,000. Finally, GFG Capital LLC acquired a new position in McKesson in the second quarter worth $30,000. 85.07% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on MCK. Wells Fargo & Company raised their price target on McKesson from $816.00 to $914.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. Morgan Stanley lifted their price target on McKesson from $857.00 to $916.00 and gave the stock an “overweight” rating in a research report on Thursday, November 6th. Jefferies Financial Group upped their price target on McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a report on Monday, October 13th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Weiss Ratings restated a “buy (a-)” rating on shares of McKesson in a research report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and a consensus target price of $892.86.
Get Our Latest Research Report on McKesson
Insider Activity at McKesson
In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm’s stock in a transaction on Friday, November 7th. The stock was sold at an average price of $861.63, for a total value of $283,476.27. Following the completion of the sale, the chief accounting officer directly owned 328 shares in the company, valued at approximately $282,614.64. This trade represents a 50.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.08% of the company’s stock.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Further Reading
- Five stocks we like better than McKesson
- Should You Invest in Penny Stocks?
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- Basic Materials Stocks Investing
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
